Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma.
Emma ButayeNicky SomersLorenz GrossarNele PauwelsSander LefereLindsey DevisscherSarah RaevensAnja GeertsLeander MeurisNico CallewaertHans Van VlierbergheXavier P D M J VerhelstPublished in: Alimentary pharmacology & therapeutics (2023)
Alterations in serum N-glycomics, characterised by increased levels of fucosylation and branching, have potential as diagnostic biomarkers for HCC. Optimisation of study design, patient selection and analysing techniques are needed before clinical implementation will be possible.